Premium
Phenothiazine therapy and plasma immunoreactive β‐MSH in schizophrenia and pruritic dermatoses
Author(s) -
SMITH A.G.,
GOOLAMALI S.K.,
THODY A.J.,
SHUSTER SAM,
PYE R.J.,
BURTON J.L.
Publication year - 1977
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1977.tb07158.x
Subject(s) - phenothiazine , schizophrenia (object oriented programming) , medicine , dermatology , pharmacology , psychiatry
SUMMARY Plasma immunoreactive β‐melanocyte‐stimulating hormone (β‐MSH) concentrations were normal in schizophrenic patients on prolonged and high dosage phenothiazine therapy. A group of patients treated with chlorpromazine 25 mg three times daily for pruritic dermatoses also showed no significant change in plasma β‐MSH concentration.